Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Zanubrutinib Capsules

Approval Number

国药准字H20200005

Company百济神州（苏州）生物科技有限公司

Registration Date

June 2, 2020

Drug Information

Generic Name

泽布替尼胶囊

Trade Name

百悦泽/BRUKINSA

Brand Name

百悦泽

Dosage Form

胶囊剂

Strength

80mg

Drug Type

化学药品

Registration Date

June 2, 2020

Company Information

Applicant Company

Company Name百济神州（苏州）生物科技有限公司

Company Address

中国（江苏）自由贸易试验区苏州片区苏州工业园区桑田街218号生物产业园9栋

Manufacturing Company

Company Name百济神州（苏州）生物科技有限公司

Company Address

中国（江苏）自由贸易试验区苏州片区苏州工业园区桑田街218号生物产业园9栋

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy